DOCSLIB.ORG

Journal of Clinical and Translational Science

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Journal of Clinical and Translational Science Journal of Clinical and Translational Science EDUCATION SPECIAL COMMUNICATION The Rockefeller University Clinical Scholars (KL2) program 2006–2016 Sarah J. Schlesinger1, Michelle Romanick1, Jonathan N. Tobin1,2, Donna Brassil1, Rhonda G. Kost1, Rita Devine1, Barbara O’Sullivan1, Roger D. Vaughan1,3, Yupu Liang1, Joel Correa da Rosa1, Maija Williams1, James G. Krueger1 and Barry S. Coller1* 1 Center for Clinical and Translational Science, Rockefeller University, New York, NY, USA 2 Clinical Directors Network, Inc., New York, NY, USA 3 Department of Biostatistics, Columbia University, New York, NY, USA Journal of Clinical and Translational Science (2017), 1, pp. 285–291 doi:10.1017/cts.2017.308 Introduction and Methods. The Rockefeller Clinical Scholars (KL2) program began in 1976 and transitioned into a 3-year Master’s degree program in 2006 when Rockefeller joined the National Institute of Health Clinical and Translational Science Award program. The program consists of ∼ 15 trainees supported by the Clinical and Translational Science Award KL2 award and University funds. It is designed to provide an optimal environment for junior translational investigators to develop team science and leadership skills by designing and performing a human subjects protocol under the supervision of a distinguished senior investigator mentor and a team of content expert educators. This is complemented by a tutorial focused on important translational skills. Results. Since 2006, 40 Clinical Scholars have graduated from the programs and gone on to careers in academia (72%), government service (5%), industry (15%), and private medical practice (3%); 2 (5%) remain in training programs; 39/40 remain in translational research careers with 23 National Institute of Health awards totaling $23 million, foundation and philanthropic support of $20.3 million, and foreign government and foundation support of $6 million. They have made wide ranging scientific discoveries and have endeavored to translate those discoveries into improved human health. Conclusion. The Rockefeller Clinical Scholars (KL2) program provides one model for translational science training. Received 29 September 2017; Revised 11 October 2017; Accepted 15 November 2017 the Armed Forces Research Institute of Medical Sciences in Thailand, we ’ Key words: Translational research, Training, KL2, master’s degree. are limiting this report to the graduates of the Master s degree program from 2006 to 2016. Introduction Background The overarching goal of The Rockefeller Clinical Scholars (KL2) program is to prepare trainees to be successful translational science investigators The Rockefeller University has been committed to excellence in the who improve human health. The program began on an informal basis in conduct and teaching of biomedical research since its founding in 1901 1976, was reorganized into a formal program in 2001, and was modified as The Rockefeller Institute for Medical Research. The founding vision into the current 3-year New York State-approved Master of Clinical was for the faculty to carry out basic research on human diseases, Investigation degree granting program in 2006 at the time of the first aided by a hospital on the campus devoted solely to research and Rockefeller Clinical and Translational Science Award (CTSA) and the education. The hospital opened in 1910 with the radically new philo- creation of the Center for Clinical and Translational Science (CCTS). sophy of the founding director, Rufus Cole, of staffing the hospital with Although a number of outstanding scholars completed the program from fulltime, salaried “physician-scientists” performing clinical and transla- 2001 to 2006 and went on to successful academic and research positions tional science at the bedside and the research bench. This model was at The National Institutes of Health, major academic medical centers, and remarkably successful, and by the time of his retirement in 1937, Cole’s trainees included 112 full-time academic faculty members * Address for correspondence: B. S. Coller, M.D., Rockefeller University, 1230 York across the country, 3 deans, 22 members of the National Academy of Avenue, New York, NY 10065, USA. Sciences, and 46 members of the prestigious Association of American (Email: [email protected]) Physicians. The Rockefeller University Hospital carries on this © The Association for Clinical and Translational Science 2018. This is an Open Access article, distributed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. Downloaded from https://www.cambridge.org/core. IP address: 170.106.202.8, on 30 Sep 2021 at 17:54:51, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/cts.2017.308 286 cambridge.org/jcts tradition today with virtually all patients in the Hospital participating in statistically, and have a compelling measurable endpoint related to the a research protocol led by full-time faculty and trainee translational health need so as to justify regulatory approval and/or clinical adoption investigators. Patients are not charged for either their medical or and implementation. Thus, the Clinical Scholars (KL2) program is hospital services. designed to provide an optimal environment for scholars to acquire each of these skills through both experiential and didactic components, coupled with the support of an extensive infrastructure of experts Methods who can guide the scholars through the development, approval, conduct, analysis, and dissemination of the results of their own pro- Program Size and Funding tocol. Team science is integral to the success of translational research and so it is emphasized throughout the program, most particularly the Based on our experience from 2001 to 2006, we found that individual requirement that all scholars serve as principal investigator (PI) of their attention to scholars, active participation by scholars in tutorials, peer own human subjects protocol. learning, and social cohesion were optimal when the program contained 15–20 scholars (online Supplementary Fig. S1). Program Organization The program has been supported by the KL2 portion of the CTSA and University funds, the latter coming both from a University endowment For the years 2006 to 2015 the CTSA PI Dr Barry Coller served as the fund and additional philanthropic support (online Supplementary Clinical Scholars (KL2) program director and Dr Sarah Schlesinger, Fig. S1). Scholars are each paid the same base amount from the pro- Associate Professor of Clinical Investigation at Rockefeller, served as gram, but mentors can provide modest supplements from their own codirector. In 2016, the director and codirector changed positions. funds to recognize extraordinary experience, expertise, or responsi- The director and codirector select a Chief Clinical Scholar (or scho- bilities—or success in obtaining external funding. To insure that the lars) each year who helps with organizational and administrative issues, scholars can devote essentially 100% of their effort to their research, assists with recruitment of new scholars, guides the scholars in their they are enjoined from performing clinical services for remuneration choice of tutorial topics, reviews the scientific quality of protocols as a (other than overnight and weekend clinical coverage in the Rockefeller member of the CCTS Advisory Committee for Clinical and Transla- University Hospital itself). At the same time, if their clinical research tional Science, and provides feedback to the program leadership. The project at Rockefeller is too limited to maintain their clinical skills, they chief scholars also play a vital role in leading the comprehensive are encouraged to perform limited clinical activities on a voluntary anonymous review of all aspects of the program by the scholars each basis at one of the nearby academic medical centers. year, along with developing and implementing important changes in the program to take advantage of new opportunities and to strengthen Program Philosophy elements that need improvement. The Clinical Scholars program administrator, Michelle Romanick, plays a vital role in insuring that the scholars meet the milestones along the timeline required for them to Translational research differs from basic investigation in that it seeks to complete the program in 3 years. use the scientific method to address a health need and so its goal is to improve human health. In contrast, basic science discovery research is designed to critically probe current scientific paradigms with the goal of Applicant Pool and Selection advancing scientific knowledge. Well-conceived and executed basic science projects always produce new knowledge because they either The Clinical Scholars (KL2) program is geared primarily for physicians, support or do not support the current scientific paradigms. In contrast, either M.D.s or M.D./Ph.D.s, who have completed or nearly the uncertainties surrounding the translation of a scientific discovery completed their clinical training, but it is also open to individuals with into a novel drug, diagnostic device, or disease prevention strategy, medically related graduate degrees.
Load more

Recommended publications
  • Rockefeller University Revenue Bonds, Series 2019A
    Moody’s: Aa1 S&P: AA NEW ISSUE (See “Ratings” herein) $46,770,000 DORMITORY AUTHORITY OF THE STATE OF NEW YORK THE ROCKEFELLER UNIVERSITY REVENUE BONDS SERIES 2019A ® Dated: Date of Delivery Due: July 1, as shown on the inside cover Payment and Security: The Rockefeller University Revenue Bonds, Series 2019A (the “Series 2019A Bonds”) are special limited obligations of the Dormitory Authority of the State of New York (the “Authority” or “DASNY”), payable solely from, and secured by a pledge of (i) certain payments to be made under the Loan Agreement dated as of October 31, 2001, as amended and supplemented, including as proposed to be amended by the Proposed Loan Agreement Amendments (as defined and described herein) (the “Loan Agreement”), between The Rockefeller University (the “University” or “Rockefeller”) and the Authority, and (ii) all funds and accounts (except the Arbitrage Rebate Fund and any fund established for the payment of the Purchase Price of Option Bonds tendered for purchase) established under the Authority’s The Rockefeller University Revenue Bond Resolution, adopted October 31, 2001, as amended (the “Resolution”) and a Series Resolution authorizing the issuance of the Series 2019A Bonds adopted on March 6, 2019 (the “Series 2019A Resolution”). The Loan Agreement is a general, unsecured obligation of the University and requires the University to pay, in addition to the fees and expenses of the Authority and the Trustee, amounts sufficient to pay, when due, the principal, Sinking Fund Installments, if any, Purchase Price and Redemption Price of and interest on all Bonds issued under the Resolution, including the Series 2019A Bonds.
    [Show full text]
  • Marc Tessier-Lavigne, a Leading Neuroscientist He Rockefeller University Campaign Mittee
    THE Rockefeller university NEWS FOR BENEFACTORS AND FRIENDS OF THE UNIVERSITY • FALL 2011 MESSAGE FROM DONORS CONTRIBUTE $628 MILLION CHAIRMAN RUSSELL L. CARSON CAMPAIGN FOR COLLABORATIVE SCIENCE EXCEEDS $500 MILLION GOAL The University’s eight-year Campaign for Collaborative Science concluded on June 30, 2011, raising $628 million in new gifts and pledges during the tenure of President Paul Nurse. The Campaign exceeded its $500 mil- lion goal and achieved all that we set out to do, and more. The generosity of our bene- factors was extraordinary. This issue of our newsletter celebrates and acknowledges those whose support is helping to advance Rockefeller’s work. As you read these pages, I hope you take pride in the Campaign’s accomplishments, including our new Collab- orative Research Center on the north campus and the 12 laboratory heads we recruited over the last eight years. The conclusion of our Campaign coincid- ed with a turning point in the University’s history. In the 2010–2011 academic year, we said goodbye to a superb president and welcomed an exceptional scientific leader to Goldberg/Esto Jeff campus as his successor. Paul Nurse became photo: president of the Royal Society in London, and Marc Tessier-Lavigne, a leading neuroscientist he Rockefeller University Campaign mittee. “Because of their commitment and generosity, and the former chief scientific officer of for Collaborative Science has conclud- the future of the University looks brighter than ever.” Genentech, succeeded him in mid-March. In ed, surpassing its $500 million goal Of the $628 million contributed to support the this issue, you will learn more about Marc and with new gifts and grants totaling Campaign, $152 million came in the form of flexible his research program in brain development $628 million.
    [Show full text]
  • Elsa C. Y. Yan Department of Chemistry Yale University 225 Prospect Street, New Haven, CT06511 Tel: (203) 436-2509, Email: Elsa
    Elsa C. Y. Yan Department of Chemistry Yale University 225 Prospect Street, New Haven, CT06511 Tel: (203) 436-2509, Email: [email protected] Website: http://ursula.chem.yale.edu/~yanlab/Index.html Education • 2000 Ph.D. (Distinction) Columbia University, New York, NY Advisor: Prof. Kenneth B. Eisenthal Thesis Title: Second Harmonic Generation as a Surface Probe for Colloidal Particles • 1999 M.Phil. Columbia University, New York, NY • 1996 M.A. Columbia University, New York, NY • 1995 B.Sc. (First Class Honors) Chinese University of Hong Kong, Hong Kong Professional Appointments 2016- Director of Graduate Studies, Department of Chemistry, Yale University, New Haven, CT 2016- Editor, Biophysical Journal, Cell Press, 2014- Professor of Chemistry, Yale University, New Haven, CT 2012-2014 Associate Professor of Chemistry, Yale University, New Haven, CT 2007-2012 Assistant Professor of Chemistry, Yale University, New Haven, CT 2014- Adjunct Professor, Chinese University of Hong Kong, Hong Kong 2010-2014 Adjunct Associate Professor, Chinese University of Hong Kong, Hong Kong 2004-2007 Postdoctoral Research Associate, Rockefeller University, New York, NY 2005-2006 Adjunct Assistant Professor, Hunter College, CUNY, New York, NY 2000-2004 Postdoctoral Fellow, UC Berkeley, CA (Mentor: Prof. Richard Mathies) Visiting Fellow, Rockefeller University, New York, NY (Mentor: Prof. Thomas Sakmar) 1995-2000 Research Assistant, Columbia University, New York, NY (Mentor: Prof. Kenneth Eisenthal) Honors and Awards • Elected Chair, Gordon Research Conference:
    [Show full text]
  • Louis Licitra-President Born: Syracuse, New York Education: SUNY Delhi, Syracuse University & Rockefeller University Resident of Bucks County for Over 30 Years
    Louis Licitra-President Born: Syracuse, New York Education: SUNY Delhi, Syracuse University & Rockefeller University Resident of Bucks County for over 30 years. Worked with FACT for over 15 years Additionally on the local event planning board for Broadway Cares/Equity Fights AIDS Previous positions include President of the New Hope Chamber of Commerce and board member for over 7 years; event planning board for The Rainbow Room LGBTQA youth group; event planning board for New Hope Celebrates PRIDE (local LGBT organization); Additional support and volunteer work with The New Hope Community Association for high school youth job placement; New Hope Arts member; New Hope Historical Society member; and fund-raising/promotion/volunteer assistance for various organizations throughout the year. Currently, co-owner of Rainbow Assurance, Inc., Title Insurance Agency offering title insurance for PA & NJ. Herb Andrus-Vice President Born: Philadelphia Education: University of Pennsylvania & Pratt Institute, Brooklyn, NY Certifications: Education and Intervention Facilitator (CDC certified.) Worked at Family Sevice Association of Bucks County as Facilitator Lifetime resident of Bucks County Volunteered at --William Way Community Center FACT Board for 3 yrs Boyd Oliver-Treasurer Born: McKeesport PA Graduated Grove City College (PA) with degree in accounting Retired CPA with major public accounting, Fortune 500 corporate and small business experience spanning over 30 years. Has owned and operated his own retail/internet businesses. When not traveling around the globe with his partner, he still enjoys the occasional special consulting assignment or project. Member: AICPA (American Institute Of CPA's) Resident of New Hope/Solebury, Bucks County for over 20 years Tim Philpot-Secretary On the board of FACT for two years and served as secretary for the past year.
    [Show full text]
  • Elizabeth a Heller Phd [email protected] | 215.523.7038
    Elizabeth A Heller PhD [email protected] | 215.523.7038 Education 2009 PhD Molecular Biology The Rockefeller University, New York, NY, USA 2002 BA Biology, magna cum laude University of Pennsylvania, Philadelphia, PA USA 1998 Diploma, honors in biology Stuyvesant High School, New York, NY USA Research 2016 - Assistant Professor, Department of Pharmacology and positions present Program in Epigenetics The University of Pennsylvania. Philadelphia, PA 2010- Postdoctoral Associate, Department of Neuroscience 2015 Icahn School of Medicine at Mount Sinai, New York, NY. Advisor: Eric J Nestler MD PhD 2003- Graduate Student, Laboratory of Molecular Biology 2009 The Rockefeller University, New York, NY. Advisor: Nathaniel Heintz PhD 1999- Undergraduate Thesis Research. Department of Biology 2002 University of Pennsylvania, Philadelphia, PA. Advisor: Ted Abel PhD 2000 Summer Research Student, Center for Neural Science New York University, New York, NY. Advisors: Joseph LeDoux PhD and Raphael Lamprecht PhD 1994- Westinghouse Research, Public Health Research Institute, New York, NY. 1998 Advisor: Barry Kreiswirth PhD Awards & 2016 Whitehall Foundation Research Grant Honors 2016 Charles E Kaufman Foundation Early Investigator Grant 2016 NARSAD Young Investigator Award 2015 Robin Chemers Neustein Postdoctoral Fellowship 2014 Keystone Symposia Scholarship, Neuroepigenetics 2013 NIDA Director’s Travel Award 2013 NIDA Individual National Research Service Award 2013 Icahn School of Medicine Postdoc Appreciation Award 2013 American College of Neuropsychopharm. Travel Award 2012 NIDA Institutional National Research Service Award 2003 Women & Science Fellowship, The Rockefeller University 2002 Phi Beta Kappa Honors Society Membership 2001 Barry M Goldwater Scholarship nominee 1998 2nd Place, St. John’s University Metro NY Science Fair 1998 Honorable mention, NYC Intl.
    [Show full text]
  • 'River Campus' Project Will Advance Science
    FALL 2015 COMMUNITY CONNECTION New ‘River Campus’ project will advance science, and beautify the public East River Esplanade Image from Rafael Viñoly Architects Image from Rafael Viñoly such as benches, high- and low-back lounge seats, and seat walls Construction of a two-acre addition to the located to maximize views; and pedestrian lighting to provide a Rockefeller University campus, including a safe and renewed waterfront experience. A noise barrier will be installed to reduce the impact of FDR traffic on bikers, joggers, and two-story laboratory building, begins this fall. other park users. The design was developed with the participation of Community Board 8 representatives, city council member Ben Kallos, and other An expansion of The Rockefeller University’s campus, to house new members of the local community. To ensure the ongoing upkeep of research space for its world-renowned bioscience faculty, is set to rise this portion of the esplanade, Rockefeller is also establishing a $1 over the FDR Drive between 64th and 68th Streets. To be known as million endowment to fund the maintenance of its landscaping in The David Rockefeller–Stavros Niarchos Foundation River Campus, it perpetuity, and has contributed $150,000 and appointed a board will house a two-story, 135,600 square-foot laboratory building in member to Friends of the East River Esplanade, a conservancy which scientists will conduct studies in genomics, neuroscience, and devoted to the esplanade restoration. immunology, among other fields, addressing some of the world’s most “This construction project is critical for the university’s continued pressing medical needs.
    [Show full text]
  • Hugh C. Hemmings, Jr., MD., Phd As Chairman of the Department Of
    Hugh C. Hemmings, Jr., MD., PhD As Chairman of the Department of Anesthesiology, Dr. Hemmings oversees the extensive clinical and basic anesthesiology research program in the department. He has authored over 100 publications including a textbook on basic anesthesiology. His clinical practice focuses on anesthesia for thoracic surgery and other high risk procedures. He leads an active research group investigating the neuropharmacology of general anesthetics, neuroprotection, cell signaling and novel analgesia therapies. A summary of education, training and/or faculty appointments is listed as following: 2018-present Senior Associate Dean for Research 2013-present Chairman and Anesthesiologist-in-Chief, Department of Anesthesiology, Weill Cornell Medical College 2001-present Professor of Pharmacology, Weill Medical College of Cornell University, New York, NY 2000-present Adjunct Faculty, Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 2000-present Attending Anesthesiologist, Weill Medical College of Cornell University, New York, NY 2000-present Professor of Anesthesiology, Weill Medical College of Cornell University, New York, NY 1999-present Vice Chair for Research, Department of Anesthesiology, Weill Medical College of Cornell University, New York, NY 1998-2001 Associate Professor of Pharmacology, Weill Medical College of Cornell University, New York, NY 1996-2000 Associate Attending Anesthesiologist, The New York Hospital, New York, NY 1996-2000 Associate Professor of Anesthesiology, Cornell
    [Show full text]
  • Elegant Molecules: [Dr. Stanford Moore] Fulvio Bardossi
    Rockefeller University Digital Commons @ RU Rockefeller University Research Profiles Campus Publications Spring 1982 Elegant Molecules: [Dr. Stanford Moore] Fulvio Bardossi Judith N. Schwartz Follow this and additional works at: http://digitalcommons.rockefeller.edu/research_profiles Part of the Life Sciences Commons Recommended Citation Bardossi, Fulvio and Schwartz, Judith N., "Elegant Molecules: [Dr. Stanford Moore]" (1982). Rockefeller University Research Profiles. Book 13. http://digitalcommons.rockefeller.edu/research_profiles/13 This Article is brought to you for free and open access by the Campus Publications at Digital Commons @ RU. It has been accepted for inclusion in Rockefeller University Research Profiles by an authorized administrator of Digital Commons @ RU. For more information, please contact [email protected]. Carbo I Leu ------Asn--------.....) THE ROCKEFELLER UNIVERSITY I 18 _ C,.---------~~----.-- ....---_...980....101_------~ His (P'o) ~-----------His--- ...../IIB RESEARCH 131 170 s 5 Diagram ofspecial pllDOIi\1CIIES features ofbovine 206 N J.L pancreatic deoxyribonuclease. ......------------Thr SPRING 1982 257 Elegant Molecules Asked how he happened to become a biochemist, Professor FROM THE GREEKPROTEIOS: Stanford Moore attributes the choice to gifted teachers of PRIMARY science and a vocational counselor who advised him that there was no future in aeronautical engineering. "But," he adds Proteins comprise the largest part of the solid mattel ofliving with a smile, ''I've never regretted the choice. I can imagine cells. Some proteins, such as the hemoglobin that carries oxy­ no life more fascinating or more rewarding than one spent gen in red blood cells, are involved in transport and stOrage. exploring the elegant and complicated architecture of organic Many hormones, like insulin, are proteins; they are chemical molecules." messengers that coordinate body activities.
    [Show full text]
  • Why a University for Chicago and Not Cleveland? Religion and John D
    Why a University For Chicago And Not Cleveland? Religion And John D. Rockefeller’s Early Philanthropy, 1855-1900 Kenneth W. Rose Assistant to the Director Rockefeller Archive Center ____________________ © 1995. This essay is a revised version of a paper prepared for the Western Reserve Studies Symposium in Cleveland, Ohio, October 6-7, 1995, and included in From All Sides: Philanthropy in the Western Reserve. Papers, Abstracts, and Program of the Tenth Annual Western Reserve Studies Symposium, sponsored by the Case Western Reserve University American Studies Program. (Cleveland: Case Western Reserve University, 1995), pp. 30-41. The author welcomes the scholarly use of the ideas and information in this essay, provided that the users properly acknowledge the source and notify the author of such citation at [email protected]. ____________________ Clevelanders sometimes seem to have a “What have you done for me lately?” attitude with regard to John D. Rockefeller. As if the creation on the Cuyahoga’s shores of one of the country’s most powerful and influential corporations is not enough, some Clevelanders look to Rockefeller’s enormous charitable giving and wonder why he built no major institution in Cleveland to provide jobs and world renown under the Rockefeller banner. Most people who express such opinions often point, with a hint of jealousy, to the University of Chicago as an example of Cleveland’s missing Rockefeller landmark. To believe that a Rockefeller-endowed University of Cleveland would today have the same academic and intellectual reputation as the present-day University of Chicago, one must assume that the same personalities and forces that shaped the University of Chicago would have been present in Cleveland, and that they would have behaved and acted exactly the same way in this different environment.
    [Show full text]
  • Convocation for Conferring Degrees Virtual Ceremony Thursday, June 11, 2020 Academic Procession New Castle Brass Quintet Welcomi
    Convocation for Conferring Degrees Virtual Ceremony Thursday, June 11, 2020 Academic Procession New Castle Brass Quintet Welcoming Remarks Richard P. Lifton, M.D., Ph.D. President and Carson Family Professor Introduction Sidney Strickland, Ph.D. Dean of Graduate and Postgraduate Studies Vice President for Educational Affairs Conferring of the Degree of Doctor of Philosophy Dr. Lifton Presentation of the David Rockefeller Award for Extraordinary Service Dr. Lifton Alzatta Fogg Torsten N. Wiesel, M.D., F.R.S. Conferring of the Degree of Doctor of Science, Honoris Causa Dr. Lifton Marnie S. Pillsbury Lucy Shapiro, Ph.D. Academic Recession New Castle Brass Quintet 2 2020 Graduates Sarah Ackerman B.S., State University of New York, College at Geneseo The Role of Adipocytes in the Tumor Microenvironment in Obesity-driven Breast Cancer Progression Paul Cohen Sarah Kathleen Baker B.A., University of San Diego Blood-derived Plasminogen Modulates the Neuroimmune Response in Both Alzheimer’s Disease and Systemic Infection Models Sidney Strickland Mariel Bartley B.Sc., Monash University Characterizing the RNA Editing Specificity of ADAR Isoforms and Deaminase Domains in vitro Charles M. Rice Kate Bredbenner B.S., B.A., University of Rochester Visualizing Protease Activation, retroCHMP3 Activity, and Vpr Recruitment During HIV-1 Assembly Sanford M. Simon Ian Andrew Eckardt Butler B.A., The University of Chicago Hybridization in Ants Daniel Kronauer Daniel Alberto Cabrera* B.A., Columbia University Time-restricted Feeding Extends Longevity in Drosophila melanogaster Michael W. Young * Participant in the Tri-Institutional M.D.-Ph.D. Program 3 James Chen B.A., University of Pennsylvania Cryo-EM Studies of Bacterial RNA Polymerase Seth A.
    [Show full text]
  • The Rockefeller Institute Review 1963, Vol. 1, No. 3 the Rockefeller University
    Rockefeller University Digital Commons @ RU The Rockefeller Institute Review The Rockefeller University Newsletters 6-1963 The Rockefeller Institute Review 1963, vol. 1, no. 3 The Rockefeller University Follow this and additional works at: http://digitalcommons.rockefeller.edu/ rockefeller_institute_review Recommended Citation The Rockefeller University, "The Rockefeller Institute Review 1963, vol. 1, no. 3" (1963). The Rockefeller Institute Review. Book 3. http://digitalcommons.rockefeller.edu/rockefeller_institute_review/3 This Book is brought to you for free and open access by the The Rockefeller University Newsletters at Digital Commons @ RU. It has been accepted for inclusion in The Rockefeller Institute Review by an authorized administrator of Digital Commons @ RU. For more information, please contact [email protected]. THE ROCKEFELLERINSTITUTE REVIEW, June 1963. Issued in February, April, June, August, October, De- cember. This is volume 1 number 3. Published by The Rockefeller Institute, 66th Street and York Avenue, New York 21, New York. Application to mail at second-class postage rate is pending at New York, N. Y. Copyright O 1963 by The Rockefeller Institute Press. Printed in the United States of America. TWO VOICES: SCIENCE AND LITERATURE , BY MARJORIE HOPE NICOLSON ius," both titles well deserved. There were revolu- \\ tions in politics, in religion, in society, in economics. I HAVE TAKEN my title from the opening phrase of one But a century that has left a roster of such names as of Wordsworth's sonnets on liberty: those of Harvey, Kepler, Galileo, Boyle, Newton, as Two voices are there; one is of the sea, Bruno, Bacon, Hobbes, Spinoza, Leibniz, Locke, One of the mountains; each a mighty voice.
    [Show full text]
  • Graduate Program in Genetics: 2018 Entering Class Dexter Adams
    Graduate Program in Genetics: 2018 Entering Class Dexter Adams: Dexter graduated with a B.S. in Molecular Biology and Zoology from U Wisconsin-Madison in 2018. As an undergraduate, he investigated the role of Gibberellins in the gravitropic stress response of Arabidopsis thaliana in the Gilroy Lab. Dexter is interested in epigenetic control of gene expression and using large scale genomic data to answer questions regarding evolutionary relationships. Likes: Watching the NBA, playing baseball, working on cars, and his tortoise Charlie Chung: Charlie received a B.S in Biology from Stony Brook University and an M.S in Biotechnology from the City College of New York. His previous research interests primarily included molecular techniques, and his recent interests involve E. coli genetics as a tool for identifying novel antibiotic targets. He hopes to broaden his knowledge to other microbes and molecular events involved in their virulence. Likes: Animals, video games, food, reading (working on it) Abhay Kanodia: Abhay completed his undergraduate degree in Biotechnology in 2014 at SRM University, India. He obtained his M.S. degree in Molecular and Cell Biology from Brandeis University in 2016. Subsequently, he worked at Sanofi- Genzyme and then at Dana Farber Cancer Institute as a laboratory technician. His research experience has piqued his interest in understanding the tumor microenvironment and immunotherapy. Likes: Hiking, swimming, cooking, binging Netflix and traveling. Cristian Lopez-Cleary: Cristian graduated in 2013 with a B.S. in Biomedical Engineering from Columbia University. He joined Stony Brook’s MD/PhD program in 2016 and is pursuing his dissertation research with the Vakoc group at Cold Spring Harbor Laboratory.
    [Show full text]